• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Sorrento Therapeutics

The top 5 MassDevice stories of the week — July 31, 2020

July 31, 2020 By Chris Newmarker

The past week has seen a slew of Q2 earnings reports from medical device companies — and the picture overall hasn’t been pretty amid the COVID-19 pandemic. Still, medtech CEOs during their earnings calls said they’re starting to see some signs of hospital procedures recovering a bit even as the southern U.S. deals with a […]

Filed Under: Business/Financial News, Diagnostics, Dialysis, Digital Health, Featured, Orthopedics, Wall Street Beat Tagged With: Aetna, Ayogo Health, Baxter, conformis, coronavirus, COVID-19, Dexcom, Hologic, MassDevice Top Five, Smith+Nephew, Sorrento Therapeutics

Sorrento licenses COVID-19 saliva test

July 30, 2020 By Sean Whooley

Sorrento Therapeutics (NSDQ:SRNE) announced that it entered into a licensing agreement with Columbia University for its COVID-19 saliva diagnostic test. The one-step diagnostic test is designed to detect SARS-CoV-2 (the virus causing coronavirus) in as little as 30 minutes from a sample of saliva. Developed by a team at Columbia, the test will be marketed […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News Tagged With: Columbia University, coronavirus, COVID-19, Sorrento Therapeutics

TriSalus touts data for pressure-enabled drug-delivery tech

November 7, 2018 By Sarah Faulkner

TriSalus Life Sciences touted results today from a Phase Ib trial of its pressure-enabled drug-delivery tech for immunotherapy. The company reported that delivering a concentrated dose of CAR-T cells at the site of a solid tumor using its technology was safe and contributed to positive clinical results. Get the full story at our sister site, Drug […]

Filed Under: Clinical Trials, Drug-Device Combinations, Oncology Tagged With: Sorrento Therapeutics, trisaluslifesciences

Sorrento Therapeutics wins FDA nod for post-shingles pain patch

February 28, 2018 By Sarah Faulkner

Shares in Sorrento Therapeutics (NSDQ:SRNE) soared today after the company announced that the FDA approved its ZTlido lidocaine pain patch designed to treat patients with post-shingles neuralgia. The company resubmitted its application for ZTlido to the FDA last year after it was rejected by the U.S. regulatory agency in 2016. Get the full story at our sister site, Drug […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pain Management, Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Sorrento Therapeutics

Scilex seeks EU nod for ZTlido lidocaine patch

November 14, 2017 By Sarah Faulkner

Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that it filed a marketing authorization application seeking approval for its ZTlido lidocaine patch. The San Diego, Calif.-based company said it is pursuing a hybrid regulatory pathway with the Medicines and Healthcare Products Regulatory Agency in the U.K., which will serve as the lead review agency. The company also plans to file […]

Filed Under: Drug-Device Combinations, Pain Management, Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Scilex Pharmaceuticals, Sorrento Therapeutics

Sorrento seeks FDA nod for lidocaine patch

August 29, 2017 By Sarah Faulkner

Sorrento Therapeutics (NSDQ:SRNE) said today that its subsidiary Scilex Pharmaceuticals resubmitted the new drug application for its lidocaine patch, ZTlido, to the FDA. The San Diego, Calif.-based company is developing the drug-device product for the relief of pain associated with post-herpetic neuralgia. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pain Management, Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Scilex Pharmaceuticals, Sorrento Therapeutics

Scilex touts head-to-head study of lidocaine pain-relief patch

June 19, 2017 By Sarah Faulkner

Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals touted data today from a head-to-head clinical adhesion study of its ZTlido lidocaine patch, comparing it to the EU reference product, Versatis. ZTlido is a lidocaine patch in development for the treatment of post-herpetic neuralgia – a severe neuropathic pain condition that affects elderly people and patients who have […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pain Management, Pharmaceutical, Wall Street Beat Tagged With: Scilex Pharmaceuticals, Sorrento Therapeutics

Scilex touts data for novel lidocaine patch

December 5, 2016 By Sarah Faulkner

Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that its lidocaine patch, ZTlido, met primary and secondary endpoints in a pivotal study comparing the patch to Endo Pharmaceutical‘s Lidoderm patch. The data will be used to resubmit a new drug application to the FDA in mid-2017, the Malvern, Pa.-based company said. The clinical trial evaluated Scilex’s […]

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA), Pain Management, Pharmaceutical, Wall Street Beat Tagged With: Scilex Pharmaceuticals, Sorrento Therapeutics

Sorrento lures ex-Hologic exec Herde | Personnel Moves April 7, 2016

April 7, 2016 By Brad Perriello

Sorrento lures ex-Hologic exec Herde Sorrento Therapeutics (NSDQ:SRNE) said it lured Kevin Herde, the former vice president of global blood screening & alliance management at Hologic (NSDQ:HOLX), to be its new CFO. Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Orchid Orthopedic, Personnel Moves, ReWalk Robotics, Sorrento Therapeutics, Trans1, Zeus Industrial Products

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy